Adjusting to life after treatment: distress and quality of life following treatment for breast cancer

E S Costanzo, S K Lutgendorf, M L Mattes, S Trehan, C B Robinson, F Tewfik, S L Roman, E S Costanzo, S K Lutgendorf, M L Mattes, S Trehan, C B Robinson, F Tewfik, S L Roman

Abstract

Clinical and anecdotal findings suggest that the completion of cancer treatment may be marked by heightened distress and disrupted adjustment. The present study examined psychological adjustment during the 3 months following treatment among 89 women with stages 0-III breast cancer. Participants completed measures of depression, cancer-related anxiety, cancer concerns, and quality of life at three time points: during treatment, 3 weeks following the end of treatment, and 3 months post-treatment. Post-treatment scores were suggestive of good psychological adjustment among the majority of women. Moreover, distress did not increase following treatment; longitudinal analyses showed no significant changes in depression or recurrence worry, while intrusive thoughts decreased, and quality of life improved. Younger age predicted greater distress across measures. A history of depression or anxiety predicted greater depressive symptomatology, while more extensive treatment predicted greater cancer-related anxiety. Despite the lack of distress endorsed on general depression and anxiety indices, participants reported moderate distress associated with cancer-related concerns, including physical problems, fear of cancer recurrence, and resuming normal life. In sum, while breast cancer survivors demonstrate good adjustment on general distress indices following treatment, some women are at risk for sustained distress. Moreover, significant cancer-related concerns are prevalent and may be important intervention targets.

Figures

Figure 1
Figure 1
Age predicts intrusion, F(1,76)=12.12, P=0.001. Age is illustrated by quartiles.
Figure 2
Figure 2
Education predicts intrusion, F(3,77)=6.77, P<0.001.
Figure 3
Figure 3
Psychiatric history predicts depression, F(1,80)=4.12, P=0.046, and the trajectory of depression over time, F(2,143)=3.50, P=0.033.
Figure 4
Figure 4
Adjuvant treatment predicts intrusion, F(1,81)=6.71, P=0.011.

References

    1. Andersen BL, Anderson B, deProsse C (1989) Controlled prospective longitudinal study of women with cancer: psychological outcomes. J Consult Clin Psychol 57: 692–697
    1. Arndt V, Merx H, Sturmer T, Stegmaier C, Ziegler H, Brenner H (2004) Age-specific detriments to quality of life among breast cancer patients one year after diagnosis. Eur J Cancer 40: 673–680
    1. Beisecker AE, Cook MR, Ashworth J, Hayes J, Brecheisen M, Helmig L, Hyland S, Selenke D (1997) Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients. Psychooncology 6: 85–93
    1. Deshields T, Tibbs T, Fan MY, Bayer L, Taylor M, Fisher E (2005) Ending treatment: the course of emotional adjustment and quality of life among breast cancer survivors immediately following radiation therapy. Support Care Cancer 13: 1018–1026
    1. Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B (1998) Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol 16: 487–494
    1. Ensel WM (1986) Measuring depression: the CES-D scale. In Social Support, Life Events, and Depression, Lin N, Dean A, Ensel WM (eds) Orlando: Academic Press
    1. Frost MH, Suman VJ, Rummans TA, Dose AM, Taylor M, Novotny P, Johnson R, Evans RE (2000) Physical, psychological and social well-being of women with breast cancer: the influence of disease phase. Psychooncology 9: 221–231
    1. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 16: 501–514
    1. Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46: 437–443
    1. Horowitz M, Wilner N, Alvarez W (1979) Impact of events scale: a measure of subjective stress. Psychosom Med 41: 209–218
    1. Horowitz MJ (1982) Stress response syndromes and their treatment. In Handbook of Stress: Theoretical and Clinical Aspects, Goldberger L, Breznitz S (eds) pp 711–732. New York: The Free Press
    1. Lethborg CE, Kissane D, Burns WI, Snyder R (2000) ‘Cast Adrift’: the experience of completing treatment among women with early stage breast cancer. J Psychosoc Oncol 18: 73–90
    1. McKinley ED (2000) Under toad days: surviving the uncertainty of cancer recurrence. Ann Intern Med 133: 479–480
    1. Moyer A, Salovey P (1996) Psychosocial sequelae of breast cancer and its treatment. Ann Behav Med 18: 110–125
    1. Mullan F (1985) Seasons of survival: reflections of a physician with cancer. N Engl J Med 313: 270–273
    1. Neugarten BL, Hagestad GO (1976) Age and the life course. In Handbook of Aging and Social Sciences, Binstock RE, Shanas E (eds) pp 35–55. New York: Van Nostrand Reinhold
    1. Osowiecki DM, Compas BE (1999) A prospective study of coping, perceived control, and psychological adaptation to breast cancer. Cognit Ther Res 23: 169–180
    1. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A: 1326–1336
    1. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1: 385–401
    1. Rowland JH, Holland JC (1990) Breast cancer. In Handbook of Psychooncology: Psychological Care of the Patient with Cancer, Holland JC, Rowland JH (eds) pp 188–207. New York: Oxford University Press
    1. Schnipper HH (2001) Life after breast cancer. J Clin Oncol 19: 3581–3584
    1. (1998) 1998 SF-36 Normative Data Vol. 2006
    1. Spitzer RL, Kroenke K, Williams JB, The Patient Health Questionnaire Primary Care Study Group (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282: 1737–1744
    1. Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR (2005) Promoting adjustment after treatment for cancer. Cancer 104: 2608–2613
    1. Vickberg SM (2003) The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 25: 16–24
    1. Ward SE, Viergutz G, Tormey D, deMuth J, Paulen A (1992) Patients' reactions to completion of adjuvant breast cancer therapy. Nurs Res 41: 362–366
    1. Ware JE, Kosinski M, Dewey JE (2000) How to Score Version Two of the SF-36 Health Survey. Lincoln, RI: QualityMetric, Incorporated
    1. Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36® Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute
    1. Wenzel LB, Fairclough DL, Brady MJ, Cella D, Garrett KM, Klushman BC, Crane LA, Marcus AC (1999) Age-related differences in quality of life of breast carcinoma patients after treatment. Cancer 86: 1768–1774

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa